INTRODUCTION
Histoplasmosis is a systemic mycosis caused by Histoplasma capsulatum, a ubiquitous dimorphic fungus isolated from several geographic regions with distinct climates. The disease is generally asymptomatic or self-limited, although severe and disseminated infections can develop depending on the number of inhaled infective propagules, strain virulence, and host’s cellular immune response1. Risk factors include presence of acquired immunodeficiency syndrome (AIDS), extremes of age, immunosuppressive drug usage, hematologic malignancies, solid organ transplantation, pregnancy, and immune reconstitution syndrome (IRS)1.
Few cases of disseminated histoplasmosis (DH) have been reported during pregnancy, especially in the second and third trimesters, in women with diabetes mellitus or HIV positivity2, but not in the postpartum period.
Here we aimed to describe the first case of DH during the postpartum period in an HIV-negative woman from an endemic area of the Brazilian Northeast and conduct a molecular analysis of the isolated H. capsulatum.
CASE REPORT
A 24-year-old woman, who was previously healthy and lived in urban area of Fortaleza, developed high fever and dry cough intensification on day 2 post vaginal delivery. The neonate was born healthy. On day 10, she was admitted to the São José Hospital of Infectious Diseases in Fortaleza, Ceará. Upon arrival at the emergency room, she was pale, dyspneic (30 breaths/min), febrile (39°C), hypotensive (blood pressure 100×60 mmHg), and tachycardic (113 beats/min). She had no lymphadenopathy and skin or oral lesions but complained of an uncommon cough that developed 2 months predelivery. Heart rhythm was normal, and pulmonary examination revealed fine crackles in the lower 2/3 of the left hemithorax. The abdomen was distended and flaccid, with painful hepatomegaly, but there was no splenomegaly.
Laboratory examinations revealed a hemoglobin level of 10 g/dL, white blood cell (WBC) count of 6,860/mm3 (84% neutrophils, 5% eosinophils, 10% lymphocytes, 1% monocytes), and platelet count of 321,000/mm3. Renal function was normal (creatinine level, 0.7, and urea level, 33 mg/dL) although lactate dehydrogenase levels were elevated (2,125 U/L). The aspartate aminotransferase level was high (67 U/L), while the alanine aminotransferase level was within normal limits (28 U/L). The arterial blood gas measurement, with a 21% fraction of inhaled oxygen, was as follows: pH=7.48, PO2=73.7 mmHg, PCO2=23.7 mmHg, and HCO3=17.3 mmol/L.
Chest radiography revealed a diffuse reticulonodular infiltrate and hilar lymphadenomegaly (Figure 1), and abdominal ultrasound showed hepatosplenomegaly and thick intrauterine liquid. HIV serology was negative.
Treatment with antituberculosis drugs, oseltamivir, levofloxacin, and dexamethasone had been initiated, although fever and dyspnea persisted, with the onset of erythematous macular pruritic skin lesions distributed in the torso and limbs, compatible with pharmacodermia. Skin biopsy was performed. Antituberculosis drug therapy was interrupted. On day 7 post-hospitalization, she developed respiratory and heart failure with refractory septic shock. Hemogram revealed a hemoglobin level of 10.6 g/dL, WBC count of 24,890/mm3 (93% neutrophils, 4% lymphocytes, 3% monocytes), and platelet count of 212,000/mm3. She was transferred to the intensive care unit, and placed on mechanical ventilation. She was then administered vasoactive drugs, and alternative treatment for tuberculosis with ethambutol, moxifloxacin, linezolid was reintroduced. In addition, piperacillin with tazobactam was initiated.
Buffy coat and respiratory sample cultures were performed. On day 12 post-hospitalization, yeast-like structures suggestive of H. capsulatum were found in the peripheral blood and later isolated in buffy coat culture. Culture and sputum smears for acid-fast bacilli were negative. Therapy with amphotericin B deoxycholate was initiated. Skin biopsy showed nonspecific chronic dermatitis with absence of microorganisms. Other laboratory analyses, such as C3, C4, and CH50 complement, rheumatoid factor, antineutrophil cytoplasm, antinuclear factor, and cryoglobulins, were all negative. A subsequent epidemiological link to a renovation in the patient’s home (30 days before the delivery) was obtained. After antifungal therapy, the patient showed slow and gradual improvement. She was discharged 58 days post-hospitalization with the use of itraconazole 400 mg/day, which was maintained for a year until full clinical recovery.
Molecular aspects
H. capsulatum DNA was extracted as previously described3. The internal transcribed spacer (ITS1-5.8S-ITS2) region of the rDNA was amplified by polymerase chain reaction (PCR) using sense primer ITS5 and antisense primer ITS4, as previously described3. The amplicon was purified using the QIAquick PCR purification Kit (Qiagen AG, Basel, Switzerland). Automated sequencing was performed using the Sequencing Platform at the Oswaldo Cruz Foundation, PDTIS/Fiocruz, Brazil, with the same primers utilized for PCR amplification. The obtained nucleotide sequence was edited and aligned with the Clustal-W program in MEGA 6.0 software, using the sequence of the H2 strain from USA (AF322377.1), available in the GenBank database, as a reference. Additionally, the consensus sequence of the CE1714 isolate was deposited in GenBank (KX756764). After analysis by BLASTn, the CE1714 isolate sequence revealed 100% similarity with the Ajellomyces capsulatus (H. capsulatum anamorph) CEMM 05-2-037 strain from Ceará.
To assess the relationship of the CE1714 isolate and other H. capsulatum isolates from different regions, phylogenetic analysis was conducted using 39 isolates retrieved from the GenBank database (Table 1). Phylogenetic analysis was performed by maximum likelihood (ML) using the PhyML software version 3.1 and neighbor-joining (NJ) method in MEGA 6.0 software. According to the Bayesian information (BI) criterion test results, implemented in jModelTest version 2.1.6, the Kimura 81 gamma distribution model was selected. The bootstrap value (bt) analyses were based on 1000 heuristic search replicates, by estimating the alpha of the gamma parameter with four categories and empiric nucleotide frequency. The nucleotide sequence of the Paracoccidioides brasiliensis (AF322389.1) and Blastomyces dermatitidis (AF322389.1) strains were used as outgroups (Figure 2). The results showed that the CE1714 isolate presents high genetic similarity with other isolates from Latin America, Mexico, and Asia. Moreover, three specific subgroups (bt >70%) were identified in both analyses: subgroup I (HST1 and HST32 – USA), subgroup II (HST2 and HST31 – USA), and subgroup III (HST3, HST71, and HST8 – Southeast Brazil).
TABLE 1: Histoplasma capsulatum strains and isolates used for ITS region analysis.
| Strain/isolate | Name | Source | Origin | GenBank |
|---|---|---|---|---|
| Hc1 | H2 | Human/HIV+ | USA | AF322377.1 |
| Hc2 | Downs | Human | USA | AF322378.1 |
| Hc3 | ES62 | Human | ES-Brazil | GU320947.1 |
| Hc4 | MS53 | Human | MS-Brazil | GU320981.1 |
| Hc5 | GO764 | Human | GO-Brazil | GU320955.1 |
| Hc6 | 157CS | Human | RS-Brazil | GU320938.1 |
| Hc7 | 3237 | Human | RJ-Brazil | GU320942.1 |
| Hc8 | 9291 | Human | RJ-Brazil | GU320940.1 |
| Hc9 | SP2414 | Human | SP-Brazil | GU320951.1 |
| Hc10 | CE1714 | Human | CE-Brazil | KX756764 |
| Hc11 | CEMM 05-2-072 | Human/HIV+ | CE-Brazil | JX051637 |
| Hc12 | CEMM 05-2-039 | Human/HIV+ | CE-Brazil | JX051639 |
| Hc13 | CEMM 05-1-098 | Human/HIV+ | CE-Brazil | JX051642 |
| Hc14 | CEMM 05-1-070 | Human/HIV+ | CE-Brazil | JX051644 |
| Hc15 | CEMM 05-1-096 | Human/HIV+ | CE-Brazil | JX051643 |
| Hc16 | CEMM 05-2-001 | Human/HIV+ | CE-Brazil | JX051647 |
| Hc17 | CEMM 05-2-034 | Human/HIV+ | CE-Brazil | JX051641 |
| Hc18 | CEMM 05-2-037 | Human/HIV+ | CE-Brazil | JX051634 |
| Hc19 | CEMM 05-2-002 | Human/HIV+ | CE-Brazil | JX051638 |
| Hc20 | JIEF | Human | CE-Brazil | GU320956.1 |
| Hc21 | HP12 | Human/HIV+ | Thailand | AB055240.2 |
| Hc22 | HP177 | Human | China | AB055237.2 |
| Hc23 | HC28 | Human/HIV+ | Argentina | KC693532 |
| Hc24 | HC1 | Human/HIV+ | Argentina | KC693507 |
| Hc25 | HC38 | Human/HIV+ | Argentina | KC693540 |
| Hc26 | HC47 | Human/HIV+ | Argentina | KC693548 |
| Hc27 | H71 | Human | Colombia | AF322384.1 |
| Hc28 | H70 | Human/HIV+ | Colombia | AF322383.1 |
| Hc29 | H68 | Human | Colombia | AF322382.1 |
| Hc30 | H62 | Human | Colombia | AF322379.1 |
| Hc31 | IFM41329 | Human | USA | AB055228.2 |
| Hc32 | IFM41659 | Human | USA | AB055230.2 |
| Hc33 | H147 | Human | Indonesia | AB055235.2 |
| Hc34 | HP3 | Human/HIV+ | Thailand | AB055238.2 |
| Hc35 | H143 | South Africa | AB055246.2 | |
| Hc36 | H147 | Human | Senegal | AB055247.2 |
| Hc37 | H90 | Horse | Egypt | AF322387.1 |
| Hc38 | H95 | Horse | Egypt | AB055249.1 |
| Hc39 | EH383 | Mexico | KP132275.1 | |
| Hc40 | EH374 | Mexico | KP132271.1 | |
| Paracoccidioides brasiliensis | Outgroup | —- | —- | AF322389.1 |
| Blastomyces dermatitidis | Outgroup | —- | —- | AF322388.1 |
ES: Espírito Santo; MS: Mato Grosso do Sul; RS: Rio Grande do Sul; RJ: Rio de Janeiro; GO: Goiás; SP: São Paulo; CE: Ceará.
FIGURE 2: Phylogenetic tree of H. capsulatum isolates. The tree was constructed using the ITS1-5.8S-ITS2 region with 39 fungal sequences retrieved from GenBank and the new sequence of the CE1714 isolate. Paracoccidioides brasiliensis (AF322389.1) and Blastomyces dermatitidis (AF322389.1) were considered outgroups. The tree was generated by BI and representative of both ML and NJ analyses. The values of bt/bt are indicated in their corresponding tree nodes.
DISCUSSION
This report describes the first case of DH in the postpartum period in an HIV-negative woman. Phylogenetic analysis demonstrated that the fungal isolate was similar to other H. capsulatum clinical isolates identified in patients from Ceará and Latin America.
During pregnancy, a relative immunosuppressive state develops, characterized by decreased Th1-type response, leading to a Th2-type response that promotes fetal antigen tolerance4,5. Moreover, local immunoreactivity at the maternal-fetal interface also shifts toward Th2 response4. In this scenario, exposure to the fungal pathogen could more frequently induce the appearance of disseminated fungal infections2.
In contrast, near or at delivery and in the postpartum period, recovery of Th1-type inflammatory responses occurs by broad immune activation, which is identified by increased regulatory T-cell and cytokine levels during these periods4,5. Some studies have suggested a significantly higher regulatory T-cell level (including CD4+ and CD8+ T lymphocytes) at delivery, which decreases with the onset of the postpartum period6,7. These changes can vary according to the type of delivery, maternal atopic status, and number of previous births5,6.
The immune response during the postpartum period constituted a complex and controversial event, given that the intense and exacerbated inflammatory response could be associated with the emergence of IRS2,8. Usually, IRS develops due to high microorganism or antigen loads in an unfavorable anatomic location. The diagnosis of IRS is based on the unmasking of occult asymptomatic infection or paradoxical worsening of clinical symptoms of an infection in course, unexplainably and despite appropriate antimicrobial therapy8.
Thus, changes in immune response near or at delivery and shortly after the onset of the postpartum period can possibly trigger the exacerbation of several infections. In this case, specifically, the histoplasmosis may have developed due to the interaction of transitory immunosuppression of pregnancy and immunological recovery during the postpartum period. IRS development in the postpartum period has been observed concomitantly with infections, such as HIV, tuberculosis, leprosy, cryptococcosis, coccidioidomycosis, and viral hepatitis8. Differentiating histoplasmosis from tuberculosis may be difficult due to similarities between the two9. It is important to highlight the lack of availability of fast and specific methods, such as antigen detection, in the diagnosis of DH in many endemic areas, including Brazil, thus delaying the diagnosis and treatment in this regions.
In the present study, we observed that the CE1714 isolate was clearly different compared with the USA strains but genetically similar to fungal isolates from Latin America, Mexico, and Asia. Additionally, Goldani et al. showed that fungal isolates obtained from skin lesions of patients with histoplasmosis from Rio Grande do Sul (Brazil) presented significant genetic similarity to other isolates from Colombia, Argentina, and Asia, although different from the H. capsulatum strain from North America10.
The ITS1-5.8S-ITS2 region is an excellent DNA barcode to identify diverse fungal species. This molecular region demonstrates considerable genetic diversity in Histoplasma spp.11Other studies conducted in Brazil also showed different genetic profiles among Histoplasma strains in America, suggesting specific microniches of the fungus in endemic areas3,12. The capacity to adapt to various and distinct environments and migratory flux of bats and individuals with Histoplasma infection have contributed significantly to this issue.
Therefore, although severe cases of histoplasmosis occur mainly in patients with AIDS, the healthcare system should be alert regarding the development of histoplasmosis in individuals with transitory immunosuppression or those undergoing immunological recovery, such as postpartum women.
